Repligen Corp at Stephens Investment Conference Transcript

Nov 16, 2023 / 04:00PM GMT
Jacob K. Johnson - Stephens Inc., Research Division - MD & Analyst

Good morning, everybody. Welcome to the Stephens Investment Conference. I'm Jacob Johnson, the Life Science Tools and Pharma Services Analyst here at Stephens. Thanks to all of you for joining. And as always, excited to have the team from Repligen here.

The guy on my left probably needs no introduction, but he's CEO, Tony Hunt. And the guy to his left is Jason Garland, the relatively new CFO. So Jason, glad to have you here with us. And then Sondra Newman is out there in the audience.

So this will be a fireside chat, Q&A. I've got plenty of questions. I'm sure some of you do as well, so I'll try to pause along the way in case anybody has any questions.

So with that preamble, Tony, maybe I'll turn it over to you for any opening comments you'd like to make. And maybe Jason, along the same lines since you're relatively new, maybe it'd be helpful for you to introduce yourself and tell us why you joined Repligen.

Anthony J. Hunt - Repligen Corporation - CEO & Director

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot